The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Guideline-based treatment utilization, treatment time, and cost of chemotherapy for metastatic colon cancer patients treated in U.S. community oncology practices from 2005 to 2009.
Yen Phung
No relevant relationships to disclose
Zhaohui Wang
Employment or Leadership Position - McKesson
Stock Ownership - McKesson
Inga Aksamit
Employment or Leadership Position - McKesson
Sarah G. Green
Employment or Leadership Position - McKesson
Karen Todoroff
Employment or Leadership Position - McKesson
Kimberly A. Bergstrom
Employment or Leadership Position - McKesson
Stock Ownership - McKesson